A detailed history of Aquatic Capital Management LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Aquatic Capital Management LLC holds 42,600 shares of BPMC stock, worth $3.85 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
42,600
Previous 2,700 1477.78%
Holding current value
$3.85 Million
Previous $291,000 1253.26%
% of portfolio
0.1%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$84.1 - $120.5 $3.36 Million - $4.81 Million
39,900 Added 1477.78%
42,600 $3.94 Million
Q2 2024

Aug 14, 2024

BUY
$85.18 - $108.78 $229,986 - $293,706
2,700 New
2,700 $291,000
Q2 2022

Aug 15, 2022

BUY
$45.23 - $70.15 $31,660 - $49,105
700 New
700 $35,000

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.4B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.